This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: National Cancer Center, Rznomics Inc.. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2019
Title: Sang Young Han: Innovator in Cancer Research
Introduction
Sang Young Han is a prominent inventor based in Busan, South Korea. He has made significant contributions to the field of cancer research, particularly through his innovative patents. With a total of 2 patents, his work focuses on developing advanced therapeutic methods for cancer treatment.
Latest Patents
Sang Young Han's latest patents include groundbreaking inventions aimed at improving cancer therapies. One of his notable patents is titled "Cancer specific-splicing ribozyme and use thereof." This invention involves a recombination vector designed for liver cancer treatment, which includes a tissue-specific promoter and a ribozyme targeting cancer-specific genes. The composition aims to provide a therapeutic method for liver cancer, enhancing the effectiveness of treatment.
Another significant patent is "Recombinant adenovirus with increased safety and anticancer activities, and use thereof." This invention describes a recombinant adenovirus that demonstrates improved in-vivo safety and tissue specificity. It incorporates a trans-splicing ribozyme linked to a cancer-specific gene, making it a promising candidate for anticancer drug development and cancer diagnostics.
Career Highlights
Throughout his career, Sang Young Han has worked with esteemed organizations such as the National Cancer Center and Rznomics Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in cancer research.
Collaborations
Sang Young Han has collaborated with notable colleagues, including Sang Jin Lee and Yun-Hee Kim. These partnerships have fostered a collaborative environment that enhances the potential for innovative breakthroughs in cancer treatment.
Conclusion
Sang Young Han's contributions to cancer research through his innovative patents highlight his dedication to improving therapeutic methods. His work continues to pave the way for advancements in cancer treatment, showcasing the importance of innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile